Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Antitumor duality of ApoE

Credit: 3D4Medical / Science Source

An miRNA network drives melanoma metastasis by blocking the newly uncovered role of apolipoprotein E (ApoE) as a suppressor of angiogenesis and cell invasion (Cell doi:10.1016/j.cell.2012.10.028).

Nora Pencheva et al. screened metastatic cells generated from human melanoma cell lines to identify miRNAs that were specifically upregulated. Three candidates—miR-1908, miR-199a-3p and miR199a-5p—showed metastatic potential in mice, and their increased expression correlated with the metastatic potential of human primary melanomas. Their collective or individual expression enhanced metastatic invasion, endothelial cell recruitment and angiogenesis, suggesting that these miRNAs have both cell-autonomous and non–cell-autonomous tumor effects. The authors then found that this miRNA network converges on two common targets—ApoE and the heat shock factor DNAJA4—which could explain its dual role in melanoma. ApoE secreted by cancer cells blocks invasion and endothelial cell recruitment by binding the receptors LRP1 in tumor cells and LRP8 in endothelial cells. As DNAJA4 upregulates ApoE, the miRNAs have two routes of limiting ApoE secretion, thus fostering metastasis.

Although further research is needed to investigate whether increasing ApoE expression can decrease metastatic disease, these findings suggest a potential new target to blunt metastasis and angiogenesis in melanoma and perhaps also in other cancer types.


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Pola, C. Antitumor duality of ApoE. Nat Med 18, 1752 (2012).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing